Pegadinhas (atenção especial)
Confusões comuns (o que costuma cair)
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases — Infectious Diseases Society of America (IDSA). 2012. DOI: 10.1093/cid/cis629
estudo: Guideline
Abrir fontePanorama
Fatores de risco
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases — Infectious Diseases Society of America (IDSA). 2012. DOI: 10.1093/cid/cis629
estudo: Guideline
Abrir fonteVírus (rinovírus, adenovírus, EBV) ou bactérias (S. pyogenes/GAS) infectam epitélio faríngeo. GAS produz toxinas e enzimas que causam inflamação local intensa. Risco de febre reumática (mimetismo molecular) e glomerulonefrite pós-estreptocócica.
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases — Infectious Diseases Society of America (IDSA). 2012. DOI: 10.1093/cid/cis629
estudo: Guideline
Abrir fonteShulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases — Infectious Diseases Society of America (IDSA). 2012. DOI: 10.1093/cid/cis629
estudo: Guideline
Abrir fonteCritérios
Exames iniciais
Exames laboratoriais
Exames de imagem
Outros exames
Diagnóstico diferencial
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases — Infectious Diseases Society of America (IDSA). 2012. DOI: 10.1093/cid/cis629
estudo: Guideline
Abrir fonteObjetivos
Primeira linha (resumo)
Farmacológico — 1ª linha
Farmacológico — 2ª linha
Situações especiais
Duração
ATB para GAS: 10 dias (exceto azitromicina 3-5d ou Pen Benzatina DU).
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases — Infectious Diseases Society of America (IDSA). 2012. DOI: 10.1093/cid/cis629
estudo: Guideline
Abrir fonteRed flags
Metas terapêuticas
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases — Infectious Diseases Society of America (IDSA). 2012. DOI: 10.1093/cid/cis629
estudo: Guideline
Abrir fonteFrequência de consultas
Retorno se piora ou sem melhora em 48-72h
Exames de controle
Metas terapêuticas
Critérios de encaminhamento
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases — Infectious Diseases Society of America (IDSA). 2012. DOI: 10.1093/cid/cis629
estudo: Guideline
Abrir fontePrimária
Secundária
Conteúdo de estudo. Não substitui diretrizes oficiais nem decisão clínica.
Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases — Infectious Diseases Society of America (IDSA). 2012. DOI: 10.1093/cid/cis629
estudo: Guideline
Abrir fonte